Valsartan Recall Cancer Lawsuits
NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.
The news that Stryker has settled some of the lawsuits filed against it by patients affected by its Rejuvenate Modular Hip Stem and ABG II Modular-Neck Hip Stem systems has many people pondering the value of the cases settled and how much their own cases are worth. Many of the details required to make that assessment remain shrouded in mystery due to the secrecy maintained by both Stryker and those who agreed to settlements about the terms agreed upon and the compensation provided. Even in the event of a mass settlement, what each individual can expect will depend solely upon his or her own circumstances and experiences while experiencing complications related to either of these products.
Despite the voluntary recall of Stryker Rejuvenate and ABG II systems, numerous lawsuits against Stryker Orthopaedics and ongoing Multi-District Litigation efforts, the fact remains that thousands of people have yet to file their rightful claim for compensation. Do a quick Google search, and you will find hundreds of websites dedicated to the discussion of Stryker hip lawsuits. Even though the voluntary Stryker hip recall may be widely publicized, it does not mean that every patient is aware of his or her legal rights or has the technological means to learn about the Stryker hip recall.
The Stryker hip implant recall has spurred litigation in New Jersey, Minnesota, and Florida. Because there are so many similar Stryker hip implant claims, the cases have been consolidated into Multi-District litigation proceedings (learn more about the Stryker MDL here) and have utilized bellwether trials to manage the discovery process for the claims.
There was a minor victory for patients that received faulty Biomet hip implants that have prematurely begun to fail. Biomet Inc. has agreed to pay a settlement of $56 million to cover injuries that were purportedly caused by their M2a Magnum and M2a 38 metal hip systems. The multi-district lawsuit that started in 2012 is compromised of hundreds of patients that have received these implants and have filed lawsuits claiming the devices caused pain, injuries and needed to be replaced.
Rejuvenate and ABG II hip implants were called off the market by Stryker Corporation in July 2012. The move came after the receipt of various complaints by the FDA (Food and Drugs Administration USA) regarding these two models. The patients who received these implants have developed various ailments including severe pain, swelling and disability.
A large medical company has offered a multibillion-dollar deal to patients who have suffered pain and distress due to the malfunctioning of one of their devices. The metal hip implant manufactured by Johnson & Johnson is claimed to be one of the most faulted implants to be sold in the past few decades.